Bliss GVS Pharma has announced a certificate confirmation from its Registrar and Share Transfer Agent, MUFG Intime India, verifying that all securities received for dematerialisation during the quarter were processed, accepted or rejected as appropriate, and duly updated in the share registry. This confirms smooth handling of securities demat requests and ensures that the relevant shares are listed on stock exchanges, reflecting accurate ownership records. This operational update maintains transparency and operational efficiency for shareholders and supports seamless trading and settlement of the company’s shares.